Business Description
Vimab Group AB
ISIN : SE0007439633
Compare
Compare
Traded in other countries / regions
VIMAB.SwedenNM4.Germany IPO Date
2015-10-02Description
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 2.24 | |||||
| Debt-to-EBITDA | 35.63 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.3 | |||||
| Beneish M-Score | -3.18 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -38.1 | |||||
| 3-Year FCF Growth Rate | -92.3 | |||||
| 3-Year Book Growth Rate | -50.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.26 | |||||
| 9-Day RSI | 82.28 | |||||
| 14-Day RSI | 74.12 | |||||
| 6-1 Month Momentum % | -9.83 | |||||
| 12-1 Month Momentum % | -11.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.79 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 197.18 | |||||
| Days Sales Outstanding | 53.72 | |||||
| Days Payable | 150.58 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -101.8 | |||||
| Shareholder Yield % | -26.06 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.76 | |||||
| Operating Margin % | -9.48 | |||||
| Net Margin % | -11.74 | |||||
| FCF Margin % | 0.67 | |||||
| ROE % | -59.28 | |||||
| ROA % | -12.78 | |||||
| ROIC % | -11.78 | |||||
| ROC (Joel Greenblatt) % | -53.23 | |||||
| ROCE % | -18.23 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 29.75 | |||||
| PS Ratio | 0.77 | |||||
| PB Ratio | 4.67 | |||||
| Price-to-Free-Cash-Flow | 116.67 | |||||
| Price-to-Operating-Cash-Flow | 116.67 | |||||
| EV-to-EBIT | -13.51 | |||||
| EV-to-Forward-EBIT | 1.8 | |||||
| EV-to-EBITDA | 109.65 | |||||
| EV-to-Revenue | 1.19 | |||||
| EV-to-Forward-Revenue | 0.57 | |||||
| EV-to-FCF | 177.04 | |||||
| Price-to-Projected-FCF | 1.44 | |||||
| Earnings Yield (Greenblatt) % | -7.4 | |||||
| FCF Yield % | 0.83 | |||||
| Forward Rate of Return (Yacktman) % | 61.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vimab Group AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 351.693 | ||
| EPS (TTM) (kr) | -1.883 | ||
| Beta | 0 | ||
| Volatility % | 95.46 | ||
| 14-Day RSI | 74.12 | ||
| 14-Day ATR (kr) | 0.788939 | ||
| 20-Day SMA (kr) | 9.3 | ||
| 12-1 Month Momentum % | -11.16 | ||
| 52-Week Range (kr) | 6.5 - 23.6 | ||
| Shares Outstanding (Mil) | 23.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vimab Group AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vimab Group AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vimab Group AB Frequently Asked Questions
What is Vimab Group AB(OSTO:VIMAB)'s stock price today?
The current price of OSTO:VIMAB is kr11.90. The 52 week high of OSTO:VIMAB is kr23.60 and 52 week low is kr6.50.
When is next earnings date of Vimab Group AB(OSTO:VIMAB)?
The next earnings date of Vimab Group AB(OSTO:VIMAB) is 2025-03-12.
Does Vimab Group AB(OSTO:VIMAB) pay dividends? If so, how much?
Vimab Group AB(OSTO:VIMAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers